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Effects of Benzothiadiazine Drugs on 
Carbohydrate Metabolism 
By JOHN M. WELLER AND PAUL E. BORONDY 
The administration of chlorothiazide 
both to man and to rats results in hyper- 
glycemia following a glucose load. Its 
administration to rats causes a decreased 
rate of glucose utilization by their adi- 
pose tissue in vitro. Chlorothiazide 
added directly to the incubating medium 
also decreases the rate of glucose utiliza- 
tion of rat adipose tissue. These effects 
of chlorothiazide are most likely due to 
both a direct action of the drug on tis- 
sue glucose metabolism and an indirect 
effect which is the result of chlorothia- 
zide causing a decrease in the level of 
serum insulin-like activity which in turn 
diminishes the activity of insulin-depen- 
dent enzymes involved in glucose metab- 
olism. 
H 
YPERGLYCEMIA has been reported in association with the administra- 
tion of benzothiadiazine drugs. 1-d It has been stressed that these com- 
pounds can cause exacerbation of existing or potential diabetes mellitus,“-‘I’ 
however, their hyperglycemic action has been noted even in normal individ- 
uals. The following studies were carried out to delineate further the altera- 
tions of carbohydrate metabolism produced by benzothiadiazines. 
METHODS AND RESULTS 
Glucose Tolermce Tests on Patients 
Two studies were carried out on patients.’ In the first, 10 patients apes 35 to 65 wcrc 
selected at random from those attending the hypertension clinic. Criteria fosr selection were 
that hypertension was not complicated by renal, cardiac or central nervous system in- 
volvement and that each patient had been on 0.5 Cm. chlorothiazide p.o. twice a day 
plus oral potassium chloride ( 1.0 Gm. t.i.d.) for no less than 6 months. Two patients 
had previously diagnosed diabetes mellitus controlled by diet alone. Each patient was 
placed on a 3 day preparatory diet containing 300 Gm. carbohydrate, 90 Gm. protein and 
2600 calories a day. On the fourth day a 3-hour glucose tolerance test was performed 
with the patient in the fasting state. The glucose load administered orally after obtaining 
a fasting blood sugar was 1.75 Gm./Kg. ideal body weight. Following the initial glucose 
tolerance test all patients were taken off of medication for one week. Each patient then 
followed the same 8-day preparatory diet prior to the second glucose tolerance test 
which was done on the seventh day off drug and in a fashion identical to the first. All 
blood sugar determinations were done on capillary blood by the Somogyi-Nelson 
method.11 
No patient showed significant elevation of fasting blood sugar in association with 
chlorothiazide therapy (table 1). One hour after carbohydrate ingestion the mean blood 
glucose of patients taking chlorothiazide was 167 mg./lOO ml. (79 mg./lOO ml. above 
the fasting value), while the mean blood glucose when patients were not taking thiazide 
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Table l.-Blood Glucose Values during Oral Glucose Tolerance 
Tests on Patients 
On Chlorothiaaide Off Chlorothiazide 
(Time in hours) (Time in hours) 
.._~ 
Patient 0 ‘4 I 1’: 1 3 0 Ii: I 11: 2 :i 
i. A. !I5 124 134 114 1 (l(i 11.5 X.5 10x 117 11:; 1 O!l !,!I 
A. S. X!\ 174 11s 156 ICI6 101 !I6 117 120 1:x,, 11X !IJ 
w. I<. hZ 131 1 :3i 122 113 :I? X6 144 I12 10x IO(i !,!, 
M. s.* !,,I 172 2x4 2ti4 244 2011 !IR 2411 22ti 104 1x7 lib 
d. S. x2 160 160 102 !I.5 100 !I4 111 140 102 99 !,,i 
M. M. x5 12’) 101 1 (I1 111 105 X3 9X 100 104 103 ,111, 
0. I<. !!,I 120 200 202 161 I.50 ‘IO 1411 1 :i.i 1 :{2 104 100 
M. A. 94 2lt: 209 1X0 1.51 102 97 ,X0 20X 1 !)X 124 !,!, 
J.. II. x:, 135 132 SC nrc vi I on I ‘?!I 115 IO!! 1 II !I” 
H. P.* !,,I 148 200 224 2no 90 X3 124 16X 131 14i l”li 
Mean > i 1.51 1 Ii7 155 1 :3x 116 !I1 lR!I 14 :i I3.I I”1 1 (IX 
IfS.I). 4.3 29 411 .57 47 x4 5.h 40 14 34 26 z .; 
_.._~~~~ 
*Patients with r,reviously diagnosed diabetes mellitus controlled by diet alone. 
All ~lucos:e values expressed AS me.,/100 ml. blood. 
was 133 mg,/100 ml. (52 mg./lOO ml. above fasting ) The tliffercncc brtwt~r~n thcx\c, 
n~e;ms is significant (p < 0.02). If the 3 known diabetic patients (RI. S. and H. I’. I 
art, rliminoted, the difference between mean blood gh~cose levels at this 1 hour tinlc, is 
still significant (p < 0.05). 
In tile sccontl study, 10 individuals age’s 25 to 40. both normotensivr nntl hypertenaivr. 
\\,ho \vc’rr not on henzothii~cliazine drugs v.~re sc~lrctetl. After it S3-tlny gluc~sc tolrrancta 
prqxtr;ltory diet. an intravenous glucosc~ tolerance test was carried out. The glucost~ lo:~d 
ww I ..j Gm./F&. body weight given over 3 to 5 minutes. I’rnous k~~tl was used for blood 
SII~;U determinations. Chlorothiazidr was then given in R dose of 0.5 Cm. pa. twice, 
tlail>.. On the seventh day, again after the preparatory diet, the intravenous g111cosc~ tol- 
(VX~YV tc.st was rcpcated. Diet and an;dyscs of blood sugars ww identical to tlwsf, of 
tlx~ first study. .4t all times, both when fasting and after the atlministration of thta XIII- 
VOX* load, mean values of blood sugars wcrc* higher when stlbjccts wcrc’ on chlorothinzitl~~ 
than whm not taking drug. IXffrrences hrtwern means, however, wcrc not significant. 
~YMY) <tlldirs were done on rats. In the first, R groups of rats, c~lch cont;i:ning 12 to 15 
itnimills, had oral glucost~ toleranct tests carried out by giving I .75 Cm. gll~cosr/K~. 
hotl!~ wc,ight throllgh a stomach tube. Blood was obtained by clipping the tail. DrlrinK 
the. following \vecli the first group of rats ate Purine Cho\~, the second ate similar fond 
\r.ith l)l;~crl)c~ tablets incorporated, and the third ate similar food with 100 WC. chloro- 
thiuide/Kg. rat/day incorporated. At thtx end of a week, oral glucose tolerancc~ tc,stk 
\\:(‘rt’ rqxxted. Results are shown ill table 2. niean hlood glucose valnes for nornull antl 
pl~~cc~lx~ groups wcrc significantly difierrnt at fasting ( p < 0.01 ) :md .3-hollr times 
( p < 0.05 ). \Iran ldood glucost~ values of chlorothiazidr rats diffcrcd significantly frr)n) 
hot11 plac~ho ;mtl control groups ( p < 0.01 at all times except 2 hours wllen p < 0.0.5 ).” 
In tlW SNYxld study, 3 groups of rats. each containing 9 to 11 anill& had or;~i 
~lucosc~ tolerance tests carried out as previously. They were then given in drinking 
uxter for _’ \vetks/Kg. rat/day, rr\pcctivrly, 100 mg. chlorothiazide, or 100 rnK. tliazoxitlr. 
or 30 mg. chlorothiazide plus 50 mg. tljazoxidc. At the end of this time glucose to1rranc.t. 
tt,sts were repented. Although mean I-~lootl gl~~cosr values of animals given drugs wert’ 
umsistultly higher than before drug ;ldInillistrRtinn, the differences did not rcnch stati 
“\\‘f, arc imlrhted to 11. A. Schork. Ph.D., for this c.ontrast-llraltj~)l~~ compari~orl 
anal!~si\. 
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Table P.-Blood Glucose Values during Oral G!ucose Tolerance Tests on Rats 
Time in Hours 
(:r.CXlp 0 ‘i 1 1 ‘,i 2 
Norrt1nl ( 12) 
hfwn 7” 119 111 99 90 
-+S.I1. 5.7 1.5 1” I(1 11 
Placebo ( 10) 
Mean HO 121 113 10:3 100 
IS.11. 3.4 11 7.1 11 .5.2 
Cldorothiuzidc ( 15) 
Mean 87 14” 127 11” 102 
-c-SD. 7.6 9 3 . . ‘3 9.8 6.0 10 
Numbrr of animals in parenthesis. All gluu~se valrles expressed as mg,/lOO ml. 1~lOOd. 
cal significance. Rats receiving the combination of chlorothiazide ant1 diazoxide did not 
show as consistent an elevation of mean hloocl glru)se vah~s. 
Five studies were done on nonfasting malcb Sprague-Dawley rats weighing 250 tn 350 
Cm. In any one study rats’ weights were approximately the same. In each study one 
group of rats was given chlornthiazide (Lyocliuril) 100 mg./Kg. body weight daily in 
drinking water for 14 to 18 days while another group drank tap water. Rats were clr- 
capitated and cpididymal fat pads removed, placecl in a buffer solution at 37 C.. cut into 
pieces which were placecl in tared flasks containing 3 ml. mnclified Krebq’ hicarhonatr 
huffer sohltion with 200 mg. glucose/100 ml. at 4 C., previously rq~lilibrated with 5 
per cent CO,-95 per cent O., at room temperature for 5 minutes. In the first 2 studies the 
peripheral Fj mm. of each fat pad were cut into 3 pieces, in the thircl it was cut into 
4 pieces, and in the last 2 studies into 8 pieces. Four pieces of fat pad, each from a clif- 
ferent rat, hut from the chlornthiazidc group or the control group, and tntalling approxi- 
mately the same weight, were in each flask. Some, media also contained chlorothiazidc~ 
(0.25 mg./ml.) and/or crystalline insulin (0.25 tmits/ml.) .* Flasks wcrc then in- 
cnbatecl at 37.ij C. for 2 hours with gentle shaking. Flasks phls tissues \\‘cre wrighcd 
after incubation. Rlcdia glncosc~ determinations lxforc and ; f I. 1 i 1 tc 1 mcu 1 Itlon \vrre clone, 
hy the Nelson-Snmogyi method.11 
The rate of decrease of glucose in the incubating n~rdium lxought ahout by the 
rpididymal fat pads of rats given chlornthiazide and of control rats is given in table 3. 
Also shown are the effects of the presence or absence of chlorothiazide and insulin in thr 
medium. In the groups of control rats, adding chlorothiazide to the medium reduced the 
rate of glucose disappearance due to these normal rats’ fat pads in 2 of %3 experiments 
( p < 0.01 > 0.001). Similarly adding cl~lorntl~iazide to medium containing insulin reduced 
the rate of glucose utilization of normal rats’ fat pads in 2 of 3 experiments (p < 0.01 > 
0.001 and <0.02 > 0.01 ), It should be noted that adding insldin to the medilum increased 
the glucose clisappcarancc rate caused by normal rats’ fat pacls in 7 of 8 experiments, i.e., 
both in the presence of and the absence of added chlornthiazidc in the medium ( p < 
0.001 in 4. < 0.05 > 0.02 in 2. and <O.Ol > 0.001). 
In the groups of rats receiving chlorothiazidc orally for 2 banks prior to sacrifice, the 
following effects were noted: the glllcose disappearance rate lxought nhont by chloro- 
thiazidc rats’ fat pads was reduced, as comparecl to that of normal rats, in all 3 cqx+ 
ments in which insulin, as well as chlorothiazidc, was alxcnt from the meclinln (11 < 0.001 1 
*Kindly supplied hy Eli Lilly and Co. 
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Table 3.-Glucose Disappearance Rates from Media Containing Epididymal Fat 
Pads of Rafs Gken Chlorothiazide and of Control Rats 
Chlorothiazide Rath (‘ontrol Hz& 
(Composition of medium) ((:am:xrsitiun of me~lioml 
DISCUSSION 
The glucosc~ tolerance tests done on patients show that long-term cl~loro- 
thiazidc therapy (6 or more months) results in a decreased rate of glucosc~ 
utilization following carbohydrate loading. Indeed. a single dose of a brnzo- 
thiatliazinc compound appears to he sufficient to cause an immediate rcbla- 
tive hyperglycemia. ” 
ly potassi& 
In view of the reported reversal of the thiazide effect 
supplementation ,I2 it is of interest that the patients on long- 
tc:rm chlorothiazide therapv who received potassium supplements showccl 
;I greakr effect of the thiazide on cwl~ohvdratr mc~tnl~olism than did tlkc 
712 WELLER AND BORONDY 
r 
a CONTROL RATS 
m THIAZIDE RATS 
WITH INSULIN; NO INSULIN ; WITH INSULIN; NO INSULIN; 
WITH THIAZIDE WITH THIAZIDE NO THIAZIDE NO THIAZIDE 
IN MEDIUM IN MEDIUM IN MEDIUM IN MEDIUM 
Fig. l.-The mean rates of glucose disappearance, each of 48 determinations 
(experiments 3, 4, and 5) expressed as mg. glucose/Gm. wet weight of epididymal 
fat pad/2 hours, of control rats (grey columns) and of rats given chlorothiazide 
(diagonally-lined columns), when incubated with or without insulin and/or chloro- 
thiazide in the medium (as shown below the columns). Standard deviations of the 
means are indicated bv lines in the centers of columns. 
patients on short-term therapy who did not take added potassium. The fact 
that the hyperglycemic action of benzothiadiazine drugs can be demonstrated 
as soon as 2 hours after a single dose of thiazide, 3 indicates that significant 
potassium loss is not a requirement for its effect on carbohydrate metab- 
olism. 
The glucose tolerance tests on rats suggest that the hyperglycemic action 
of chlorothiazide can be demonstrated even in the normal animal, i.e., in 
which a prediabetic state presumably is not present. Other investigators 
have also found that chlorothiazide has a hyperglycemic effect in the rat,‘” 
however, in one recent study this action was not evident despite large doses 
of chlorothiazide and even the addition of a potassium deficient diet.r4 The 
administration of a carbohydrate load would seem to be useful in making 
the hyperglycemic action of thiazides more apparent. Other thiazides, and 
especially diazoxide, also have been reported to cause hyperglycemia in the 
rat.‘;‘~‘” In the present study diazoxide appeared to ha\Te an action quite simi- 
lar to that of chlorothiazide. No synergism was evident when these 2 drugs 
were given together. 
The experiments with rat epididymal fat pad show both in vivo and in 
vitro effects of chlorothiazide. When the drug is given to the rat, the ani- 
mal’s incubated fat pad demonstrates a reduced rate of glucose disappear- 
ance from the medium. This occurs both when insulin is and is not added 
to the medium, although adding insulin increases the disappearance rate of 
glucose when the fat pad from the chlorothiazide rat is present as it does 
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when that from the normal rat is incubated. Adding chlorothiazide to the 
medium further reduces the rate of utilization of glucose brought about bv 
the epididymal fat pads of rats given chlorothiazide. This same effect on 
glucose metabolism of adding chlorothiazide to the medium is seen with 
normal rats’ fat pads. With both normal and chlorothiazitle-treated rats’ fat 
pads, however, insulin is able to increase the rate of glucose disappearance 
even when chlorothiazide is in the incubating medium. 
The hyperglycemia due to thiazides might result from: (1) interference with 
glucose transport into the cell, (2) 1 c ecrease in the rate of glucose phosphoryla- 
tion, (3) decrease in the rate of formation of glycogen, (4) decrease in the rate 
of lipogenesis. (5) increase in the rate of glycogen breakdown, or (6) in- 
crease in the rate of formation of glucose from protein. The evidence sug- 
gests that more than one of these mechanisms is playing a role. It has been 
reported that the benzothiadiazine drugs decrease serum insulin-like activ- 
itv.‘;.‘” Such :I decrease would lead to a diminished rate of transport of gllj- 
cost into those cells where this requires insulin. That interference with th(l 
glucose transport system is not the entire cause of thiazide hyperglycemia is 
shown bv studies on rat liver homogenates in which glucokinase, which is i 
in\~olvctl in glucose utilization. < and dihydroxyacetone-kinase enzyme activ- 
iticas are redllced by the administration of chlorothiazide to rats.‘!’ These 
c~nzymes are insulin-dependent, so that a lowering of serum insulin levels 
would decrease their activities. That either a diminution in the rate of forma- 
tion ot glycogen or an increase in glvcogen breakdown results from thiazidc 
administration is supported bv the finding that diazosidc decreases liver 
glycogc-ii content.‘;’ It is of in&rest that tolbutamidc administration abolishes 
the hvperglycemic effect of thiazides.‘3.1’i This might be due to tolbutamide 
increasing serum insulin-like activity sufficientlv to cause an increase in activ- 
itv of insulin-dependent enzymes. If in thiazide-treated patients the decrease i 
ill serum insulin-like activity is due to the thiaziclr interfering with the in- 
srllin-release mechanism, tolbutamide must overcome this interference. .in 
additional action of thiazide drugs is necessitated bv the observation that 
chlorothiazide added directly to the incubating medium decreases g111cosc 
utilization of epididymal fat pad. This points to a direct tisslle effect: its 
exact site of action is unknown. 
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